Centre for Infection and Immunity of Lille, U1019-UMR8204, Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France.
Inserm U995-LIRIC-Lille Inflammation Research International Center, Université Lille, CHU Lille, Lille, France.
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01450-19. Print 2019 Oct.
The escalating burden of antibiotic drug resistance necessitates research into novel classes of antibiotics and their mechanism of action. Pyrrolomycins are a family of potent natural product antibiotics with nanomolar activity against Gram-positive bacteria, yet with an elusive mechanism of action. In this work, we dissect the apparent Gram-positive specific activity of pyrrolomycins and show that Gram-negative bacteria are equally sensitive to pyrrolomycins when drug efflux transporters are removed and that albumin in medium plays a large role in pyrrolomycin activity. The selection of resistant mutants allowed for the characterization and validation of a number of mechanisms of resistance to pyrrolomycins in both and an Δ mutant, all of which appear to affect compound penetration rather than being target associated. Imaging of the impact of pyrrolomycin on the Δ mutant using scanning electron microscopy showed blebbing of the bacterial cell wall often at the site of bacterial division. Using potentiometric probes and an electrophysiological technique with an artificial bilayer lipid membrane, it was demonstrated that pyrrolomycins C and D are very potent membrane-depolarizing agents, an order of magnitude more active than conventional carbonyl cyanide -chlorophenylhydrazone (CCCP), specifically disturbing the proton gradient and uncoupling oxidative phosphorylation via protonophoric action. This work clearly unveils the until-now-elusive mechanism of action of pyrrolomycins and explains their antibiotic activity as well as mechanisms of innate and acquired drug resistance in bacteria.
抗生素耐药性负担不断增加,这就需要研究新型抗生素及其作用机制。吡咯霉素是一类具有强大活性的天然产物抗生素,对革兰氏阳性菌具有纳摩尔级的活性,但作用机制尚不清楚。在这项工作中,我们剖析了吡咯霉素明显的革兰氏阳性菌活性,并表明当去除革兰氏阴性菌的药物外排转运蛋白时,它们与吡咯霉素同样敏感,并且培养基中的白蛋白在吡咯霉素活性中起着重要作用。耐药突变体的选择使得能够对 中吡咯霉素耐药的多种机制进行表征和验证,以及 Δ 突变体,所有这些机制似乎都影响化合物的穿透,而不是与靶标相关。使用扫描电子显微镜观察吡咯霉素对 Δ 突变体的影响表明,细菌细胞壁在细菌分裂部位经常出现起泡。使用电位探针和带有人工双层脂质膜的电生理学技术,证明吡咯霉素 C 和 D 是非常有效的膜去极化剂,比传统的羰基氰化物-氯代苯腙(CCCP)活性高一个数量级,特别是通过质子易位作用扰乱质子梯度并解偶联氧化磷酸化。这项工作清楚地揭示了吡咯霉素迄今为止尚不清楚的作用机制,并解释了它们的抗生素活性以及细菌固有和获得性耐药的机制。